The Medicines Co (MDCO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

8 SYLVAN WAY PARSIPPANY, NJ 07054

Operates as a pharmaceutical company that specializes in acute care hospital products. Its first acute care hospital product, Angiomax (bivalirudin), is a direct thrombin inhibitor used as an anticoagulant in patients undergoing coronary angioplasty.

Data based on most recent fiscal year report
Market Cap2.341 Billion Shares Outstanding72.9 Million Avg Volume2.254 Million
1-Yr BETA vs S&P TR1.255 Current Ratio3.21 Quick Ratio3.18
View SEC Filings from MDCO instead.
Q2 2019 All Institutions Hedge Funds 1
To trade MDCO now:
Filers who had this stock in their top 10: 7 10 (1.03%)
13F Filers holding this stock: 225 42 (4.34%)
Aggregate 13F shares on 06/30/2019: 102.434 Million 22.663 Million
Aggregate 13F shares on 03/31/2019: 99.662 Million 21.061 Million
Percent change: 2.78% 7.61%
Funds creating new positions: 51 17
Funds Adding to an existing position: 90 13
Funds closing out their position: 25 8
Funds reducing their position: 57 12
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

 

The Medicines Co Chart by YCharts

Yahoo! Finance

finviz

Check out our reporting and analysis

Funds Holding MDCO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MEANWELL CLIVE CHIEF INNOVATION OFFICER

  • Officer
  • Director
 290,810 2019-08-30 4

RODIN STEPHEN M EVP AND GENERAL COUNSEL

  • Officer
 28,630 2019-08-30 4

TIMNEY MARK CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 30,280 2019-08-30 4

WIJNGAARD PETER CHIEF DEVELOPMENT OFFICER

  • Officer
 2,448 2019-08-30 3

ESHELMAN FREDRIC N

  • Director
 1,604,584 2019-08-16 0

DENNER ALEXANDER J

  • Director
 4,216,092 2019-06-28 9

SBLENDORIO GLENN

  • Director
 28,078 2019-06-27 0

KELLEY JOHN P

  • Director
 0 2019-06-19 0

GERMANO GENO J

0 2019-06-05 1

KELLY JOHN C.

  • Director
 32,148 2019-05-30 1

PANAYIOTOPOULOS PARIS

  • Director
 13,881 2019-05-30 1

SCHLESINGER SARAH J.

  • Director
 7,429 2019-05-30 1

SAVAGE ROBERT G.

199,869 2019-05-14 0

HUGIN ROBERT J

  • Director
 5,285 2019-04-30 0

COX CHRISTOPHER T EVP & CHIEF CORP. DEV. OFFICER

  • Officer
 392,942 2019-03-04 4

VISIOLI CHRISTOPHER CHIEF FINANCIAL OFFICER

  • Officer
 7,252 2019-03-04 2

SPIGELMAN MELVIN K

  • Director
 48,305 2018-08-15 0

KINGSLEY STUART A

  • Director
 0 2018-06-08 0

KESSLER ARMIN M

  • Director
 138,493 2018-05-10 0

WYATT ELIZABETH H S

  • Director
 60,633 2018-03-22 0

CROUSE WILLIAM

  • Director
 53,133 2018-03-21 0

O'CONNOR WILLIAM BERNARD CHIEF FINANCIAL OFFICER

  • Officer
 21,882 2018-03-02 0

FRAZIER JEFF EVP, CHIEF HUMAN STRATEGY

  • Officer
 34,350 2018-03-02 0

FURSE BRENT

0 2018-01-05 0

SHIGETA HIROAKI

  • Director
 26,784 2017-05-25 0

KUSIAK VICTORIA EVP, CHIEF INTEGRITY OFFICER

  • Officer
 3,519 2014-03-03 0

HEIMAN CORNELIS EVP, CHIEF INNOVATION OFFICER

  • Officer
 11,457 2014-03-03 0

ANTINORI PAUL MICHAEL SR. VP & GENERAL COUNSEL

  • Officer
 No longer subject to file 2014-02-25 0

ROHRBACKER LESLIE C VP, CHIEF HUMAN STRATEGY OFFIC

  • Officer
 13,628 2012-02-21 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD PARTNERS, LP

DEERFIELD MANAGEMENT CO /NY

DEERFIELD INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
 No longer subject to file 2011-04-04 0

JOHNSON T SCOTT

  • Director
 No longer subject to file 2009-07-21 0

WATSON PACICCO KELLI SENIOR VICE PRESIDENT

  • Officer
 2,211 2009-02-20 0

NEWBERRY CATHARINE S SENIOR VICE PRESIDENT

  • Officer
 No longer subject to file 2009-01-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

WIJNGAARD PETER - Officer CHIEF DEVELOPMENT OFFICER

2019-08-30 A 491 $21.60 a 2,448 2,448.00 direct

RODIN STEPHEN M - Officer EVP AND GENERAL COUNSEL

2019-08-30 A 491 $21.60 a 28,630 28,630.00 direct

MEANWELL CLIVE - Director - Officer CHIEF INNOVATION OFFICER

2019-08-30 A 491 $21.60 a 290,810 290,810.00 direct

TIMNEY MARK - Director - Officer CHIEF EXECUTIVE OFFICER

2019-08-30 A 491 $21.60 a 30,280 30,280.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments